L-Dopa Causing Adverse Effects in Therapeutic Use
1 clinical trials · Condition
◉ Watch L-Dopa Causing Adverse Effects in Therapeutic Use
| Record | Firm | Date |
|---|---|---|
| AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia (NCT04147949) | VistaGen Therapeutics, Inc. | 2022-08-01 |
Track L-Dopa Causing Adverse Effects in Therapeutic Use automatically
Every clearance here is in the API, with alerts when new ones post.